Cagrilintide Peptide for Weight Loss Appetite Control & Metabolic Support Cagrilintide: What It Is and How It's Being Studied for Weight Loss Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Targeting the weight within: obesity pharmacotherapy in cardiovascular disease Medicine Today